Edition:
United States

People: Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

3.59USD
19 Jun 2019
Change (% chg)

$0.07 (+1.99%)
Prev Close
$3.52
Open
$3.50
Day's High
$3.60
Day's Low
$3.49
Volume
44,739
Avg. Vol
33,083
52-wk High
$4.30
52-wk Low
$2.00

Livnat Savitsky, Kinneret 

Dr. Kinneret Livnat Savitsky has been appointed Director at Compugen Ltd. effective June 11, 2018. Dr. Livnat Savitsky's work experience includes the following roles: Vice President - Biology, Research & Development at the Company (2000-2004), Interim Chief Executive Officer and Board Member of FutuRx Ltd., Director at various companies, Consultant and Chief Executive Officer at BioLineRx Ltd. (2010-2016). Dr. Livnat Savitsky holds a Bachelor of Science degree in Biochemistry from Tel Aviv University, a Bachelor of Science degree in Biology from The Hebrew University of Jerusalem and a Master of Science degree and a Doctorate of Science degree, both in Human Genetics from Tel Aviv University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --